Development of a new therapy and pathologic elucidation in the diabetes retinopathy by adipocytokine
Project/Area Number |
23792023
|
Research Category |
Grant-in-Aid for Young Scientists (B)
|
Allocation Type | Multi-year Fund |
Research Field |
Ophthalmology
|
Research Institution | Kansai Medical University |
Principal Investigator |
JO Nobuo 関西医科大学, 医学部, 講師 (50411533)
|
Project Period (FY) |
2011 – 2012
|
Project Status |
Completed (Fiscal Year 2012)
|
Budget Amount *help |
¥2,730,000 (Direct Cost: ¥2,100,000、Indirect Cost: ¥630,000)
Fiscal Year 2012: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2011: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
|
Keywords | 眼病理学 / アディポサイトカイン |
Research Abstract |
Pathologic elucidation of the adipocytokine in diabetic retinopathy was considered. Although the concentration of the adiponectin in the vitreous body of diabetic retinopathy was measured, it was not a significant increase. A significant change was not accepted even if divided at the stage. Other adipocytokine was not detectable concentration within the vitreous body.A possibility that change of adipocytokine had not taken place on an eye part was suggested, and morbidity participation of adipocytokine was not clear at present.
|
Report
(3 results)
Research Products
(17 results)